Literature DB >> 19151

Recovery from toxicity associated with high-dose methotrexate: prognostic factors.

H Chan, W E Evans, C B Pratt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 19151

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  10 in total

1.  Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma.

Authors:  D J Grimes; M R Bowles; J A Buttsworth; D B Thomson; P J Ravenscroft; P F Nixon; R F Whiting; S M Pond
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

2.  Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections.

Authors:  Karen D Wright; John C Panetta; Arzu Onar-Thomas; Wilburn E Reddick; Zoltan Patay; Ibrahim Qaddoumi; Alberto Broniscer; Giles Robinson; Frederick A Boop; Paul Klimo; Deborah Ward; Amar Gajjar; Clinton F Stewart
Journal:  Cancer Chemother Pharmacol       Date:  2014-10-24       Impact factor: 3.333

3.  Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Authors:  W E Evans; C B Pratt; R H Taylor; L F Barker; W R Crom
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.

Authors:  A D Pearson; S Mills; H A Amineddine; D R Long; A W Craft; J M Chessells
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

6.  Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.

Authors:  H J Cohen; N Jaffe
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

7.  Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism.

Authors:  K Rouse; E Nwokedi; J E Woodliff; J Epstein; V S Klimberg
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

8.  Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.

Authors:  Jennifer L Pauley; John C Panetta; Kristine R Crews; Deqing Pei; Cheng Cheng; John McCormick; Scott C Howard; John T Sandlund; Sima Jeha; Raul Ribeiro; Jeffrey Rubnitz; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Cancer Chemother Pharmacol       Date:  2013-06-13       Impact factor: 3.333

9.  Prevention of chronic radiation enteropathy by dietary glutamine.

Authors:  J C Jensen; R Schaefer; E Nwokedi; D W Bevans; M L Baker; A A Pappas; K C Westbrook; V S Klimberg
Journal:  Ann Surg Oncol       Date:  1994-03       Impact factor: 5.344

10.  Glutamine: A novel approach to chemotherapy-induced toxicity.

Authors:  Kumar Gaurav; R K Goel; Mridula Shukla; Manoj Pandey
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.